# EDGAR Filing Document

**Accession Number:** 0001937891
**File Stem:** 0000000000-25-009526
**Filing Date:** 2025-9
**Character Count:** 4380
**Document Hash:** 75e00aef065d09ab2f00299b2d74f794
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-009526.hdr.sgml**: 20251125

**ACCESSION NUMBER**: 0000000000-25-009526

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250904

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AlphaVest Acquisition Corp.
- **CENTRAL INDEX KEY:** 0001937891
- **STANDARD INDUSTRIAL CLASSIFICATION:** RETAIL-HOME FURNITURE, FURNISHINGS & EQUIPMENT STORES [5700]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 001-41574

**BUSINESS ADDRESS:**
- **STREET 1:** 420 LEXINGTON AVE, SUITE 2446
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10170
- **BUSINESS PHONE:** 917-353-8978

**MAIL ADDRESS:**
- **STREET 1:** 420 LEXINGTON AVE, SUITE 2446
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10170
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001641172-25-025010

## Text-Extract

```

                                                             September 4, 2025

David Yan
Chief Executive Officer
AlphaVest Acquisition Corp.
205 W. 37th Street
New York, NY 10018

       Re: AlphaVest Acquisition Corp.
           Preliminary Proxy Statement on Schedule 14A
           Filed August 21, 2025
           File No. 001-41574
Dear David Yan:

       We have reviewed your filing and have the following comment(s).

       Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.

       After reviewing your response to this letter, we may have additional
comments.

Preliminary Proxy Statement on Schedule 14A
Risk Factors
Nasdaq may delist our securities from trading on its exchange, which could
limit investors'
ability..., page 39

1.     We note that you are seeking to extend your termination date to January
22, 2026, a
       date which is 37 months from your initial public offering. We also note
that you are
       currently listed on Nasdaq and that Nasdaq Rule 5815 was amended
effective October
       7, 2024 to provide for the immediate suspension and delisting upon
issuance of a
       delisting determination letter for failure to meet the requirement in
Nasdaq Rule IM
       5101-2(b) to complete one or more business combinations within 36 months
of the
       date of effectiveness of its IPO registration statement. Please revise
to state that your
       securities will face immediate suspension and delisting action once you
receive a
       delisting determination letter from Nasdaq after the 36-month window
ends on
       December 22, 2025. Please disclose the risks of non-compliance with this
rule,
       including that under the new framework, Nasdaq may only reverse the
determination
       if it finds it made a factual error applying the applicable rule. In
addition, please also
       disclose the consequences of any such suspension or delisting, including
that your
 September 4, 2025
Page 2

       stock may be determined to be a penny stock and the consequences of that
       designation, that you may no longer be attractive as a merger partner if
you are no
       longer listed on an exchange, any potential impact on your ability to
complete an
       initial business combination, any impact on the market for your
securities including
       demand and overall liquidity for your securities, and any impact on
securities holders
       due to your securities no longer being considered    covered securities.

        We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.

       Please contact Kate Beukenkamp at 202-551-3861 or Donald Field at
202-551-3680
with any questions.

                                                            Sincerely,

                                                            Division of
Corporation Finance
                                                            Office of Trade &
Services
cc:   Michael Blankenship

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._